Welcome to 2023 Stanford Drug Discovery Symposium. This symposium provides a valuable and important platform for inspiring interdisciplinary exchange at the forefront of drug research and will support a fantastic networking experience. It provides a great resource for researchers, pharmaceutical companies, investment groups, and those in the wider biomedical community interested in discovering new drugs and improving patient care. We look forward to an exciting two days of talks and discussion.
— Joseph C. Wu, MD, PhD | Director, Cardiovascular Institute
Participants
Hal Barron, MD
CEO, Altos Labs
Robert A. Bradway, MBA
Chairman & CEO, Amgen
Namandje Bumpus, PhD
Chief Scientist, FDA
Louis J. DeGennaro, PhD
President & CEO, Leukemia & Lymphoma Society
Aida Habtezion, MD
CMO and Head of Worldwide Medical & Safety, Pfizer
Sandra Horning, MD
Former Executive Vice President, Head of Global Product Development, and CMO, Genentech/Roche
Fady Malik, MD, PhD
Executive Vice President of Research & Development, Cytokinetics
Fiona Marshall, PhD
President, Novartis Institutes for BioMedical Research
Maria T. Millan, MD
President and CEO, California Institute for Regenerative Medicine
Daniel O’Day, MBA
Chairman and CEO, Gilead Sciences
John Reed, MD, PhD
Executive Vice President, Pharmaceuticals, R&D, Johnson & Johnson
Jim Tananbaum, MD
CEO and Founder, Foresite Capital Management, LLC
Steve Yang, PhD
Co-CEO, WuXi AppTec
Monica Beam, PhD
Senior Vice President, Science & Technology, Alexandria Real Estate Equities, Inc/Alexandria Venture Investments
Joshua Bleharski, PhD
Managing Director, Healthcare Investment Banking, J.P. Morgan
Robert Califf, MD, MACC
FDA Commissioner
Mikael Dolsten, MD, PhD
CSO and President, Worldwide Research, Development and Medical, Pfizer
Alexander Hardy, MBA
CEO, Genentech
Najat Khan, PhD
Chief Data Science Officer & Global Head, Strategy and Operations, R&D, The Janssen Pharmaceutical Companies of Johnson and Johnson
Mathai Mammen, MD, PhD
CEO Designate, FogPharma, Former EVP J&J Pharmaceuticals R&D
Mark McClellan, MD, PhD
Director and Robert J. Margolis, MD, Prof of Business, Medicine and Policy, Duke-Margolis Ctr for Health Policy
Lloyd Minor, MD
Carl and Elizabeth Naumann Professorship for the Dean, Stanford School of Medicine
Merdad Parsey, MD, PhD
Chief Medical Officer, Gilead Sciences
George W. Sledge, MD
Executive Vice President and CMP, Caris Life Sciences
Marc Tessier-Lavigne, PhD
President and Bing Presidential Professor
Stanford University
Helen Blau, PhD
Donald E. and Delia B. Baxter Foundation Professor, Director, Baxter Laboratory for Stem Cell Biology
Nancy Brown
CEO, American Heart Association
Patrizia Cavazzoni, MD
Director, Center for Drug Evaluation and Research, FDA
Levi Garraway, MD, PhD
Executive VP, Head of Product Development, and Chief Medical Officer, Genentech/Roche
Bob Harrington, MD
Arthur L. Bloomfield Professor of Medicine and Chair, Department of Medicine, Stanford School of Medicine
John Lepore, MD
Senior Vice President of Research, GSK
Peter Marks, MD, PhD
Director, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA)
Michelle McMurry-Heath, MD, PhD
Former President and CEO, Biotechnology Innovation Organization
Frank O. Nestle, MD, FMedSci
Global Head of Research, Chief Scientific Officer, Sanofi
Andrew Plump, MD, PhD
President, R&D, Takeda Pharmaceutical Company
Lip-Bu Tan, MBA
Managing Partner, Walden Catalyst
Hannah Valantine, MD
Professor of Cardiovascular Medicine, Stanford School of Medicine
Fireside Chat with Nobel Laureates
Carolyn Bertozzi, PhD
Nobel Laureate 2022; Baker Family Director of Stanford ChEM-H
Roger Kornberg, PhD
Nobel Laureate 2006; Mrs. George A. Winzer Professor of Medicine, Stanford University
Jennifer Doudna, PhD
Nobel Laureate 2020; Li Ka Shing Chancellor’s Chair Professor at UC Berkeley
Brian Kobilka, MD
Nobel Laureate 2012; Helene Irwin Fagan Chair of Cardiology, Stanford University
Lifetime Achievement Awardee
Brian Druker, MD
Jeld-Wen Chair of Leukemia Research and Director, Knight Cancer Institute, Oregon Health & Science University
Organizers
Amanda Chase, PhD
Associate Director of Strategic Research Development
Stanford Cardiovascular Institute
Kuldev Singh, MD
Professor of Ophthalmology
Stanford University School of Medicine
Sanjay Malhotra, PhD
Professor, Cell, Developmental & Cancer Biology; Director, Center for Experimental Therapeutics
OHSU
Joseph Wu, MD, PhD
Director, Stanford CVI
Simon H. Stertzer, MD, Professor, Department of Medicine and Radiology
Stanford University School of Medicine
Mark Mercola, PhD
Professor of Medicine
Stanford University School of Medicine
Francesca Mae G. Tongco, MS-HCA
Project Coordinator
Stanford Cardiovascular Institute
Platinum Sponsors
Gold Sponsors
Silver Sponsors
Media Sponsors
For additional information, please contact Joseph C. Wu, MD, PhD, or Francesca Tongco.